glp 1 agonists diabetes The Unstoppable Rise of GLP-1 Agonists: Revolutionising and Obesity Treatment GLP-1 Receptor Agonists as Treatments
Description
GLP-1 Receptor Agonists: Reminder of the Potential Side Effects and to be Aware of the Potential for Misuse
The SURMOUNT trials showed that tirzepatide produced even greater weight reductions, in some cases exceeding 20% of baseline body weight
MyStart's differentiator is its emphasis on lifestyle change as a complement to medication the platform recognizes that GLP-1s work best when combined with dietary and behavioral modifications
Using them for cosmetic weight loss or without medical supervision can be dangerous
2024 Sep 19;263(1):e240046
In crude analyses, the use of GLP-1 receptor agonists generated an elevated hazard ratio compared with the use of DPP-4 inhibitors (crude hazard ratio 2.08, 95% confidence interval (CI) 1.83 to 2.36)
